Now livetag icon
Ad Intelligence Presents: Ads in ChatGPT & Google. Download the reportbanner icon

Oncoblast app analytics for May 31

Oncoblast

Oncoblast

  • BINAYTARA FOUNDATION
  • Apple App Store
  • Free
  • Education
The OncoBlast app, created by the Binaytara, offers a unique gaming experience for hematology and oncology providers. This app allows medical professionals in hematology and oncology to engage in educational games, enabling them to earn continuing education credits while playing. OncoBlast is available at no cost and provides interactive, real-time feedback to enhance learning experiences for providers. Binaytara is a non-profit organization dedicated to improving healthcare outcomes through advocacy, education, and innovation. Founded with a vision to create a significant impact in the healthcare sector, Binaytara focuses on addressing gaps in medical knowledge and practice, especially in the fields of hematology and oncology. Their commitment to education and training extends beyond traditional methods, embracing technology and interactive platforms to reach a broader audience of healthcare professionals. This app, Oncoblast, takes us one step closer towards this commitment.
Oncoblast

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Education in
United States--
Create an account to see avg.monthly downloadsContact us

Oncoblast Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Oncoblast

Rank

No Data Available

Oncoblast Ranking by Country

Counties in which Oncoblast has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Hemeonc Questions

Hemeonc Questions

Bishal Bhandari

ASCO-SEP®

ASCO-SEP®

American Society of Clinical Oncology

RTP Live - Events

RTP Live - Events

Research To Practice

HOPA Events

HOPA Events

HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION, INC.

Oncoblast VS.

May 31, 2026